Gevo (GEVO)

1.67 +0.00  +0.00%  May 17, 8:00PM
Add to Watchlists Create an Alert

Gevo R&D Expense Quarterly:

4.976M for March 31, 2013
View Full Chart

Gevo R&D Expense Quarterly Chart

    Gevo Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 4.976M
    Dec. 31, 2012 4.352M
    Sept. 30, 2012 5.401M
    June 30, 2012 4.723M
    March 31, 2012 4.955M
    Dec. 31, 2011 5.938M
    Sept. 30, 2011 5.211M
    June 30, 2011 5.338M
    March 31, 2011 3.266M
       
    Dec. 31, 2010 3.388M
    Sept. 30, 2010 3.554M
    June 30, 2010 3.21M
    March 31, 2010 4.668M
    Dec. 31, 2009 3.778M
    Sept. 30, 2009 2.845M
    June 30, 2009 2.065M
    March 31, 2009 1.82M

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    GEVO R&D Expense Quarterly Benchmarks

    Companies
    Amyris 15.75M
    BioFuel Energy Corporation
    Synthesis Energy Sys

    GEVO R&D Expense Quarterly Rankings

    Overall 89th percentile
    833 of 7590
    Sector 89th percentile
    45 of 428 in Basic Materials
    Industry 68th percentile
    17 of 54 in Specialty Chemicals

    GEVO R&D Expense Quarterly Range, Past 5 Years

    Minimum 1.820M Mar 2009
    Maximum 5.938M Dec 2011
    Average 4.088M